Commons Capital LLC Increases Stock Position in Medifast, Inc. (NYSE:MED)

Commons Capital LLC raised its holdings in shares of Medifast, Inc. (NYSE:MED) by 38.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 38,000 shares of the specialty retailer’s stock after purchasing an additional 10,563 shares during the period. Commons Capital LLC owned approximately 0.35% of Medifast worth $670,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Millennium Management LLC lifted its holdings in shares of Medifast by 37.8% during the second quarter. Millennium Management LLC now owns 469,216 shares of the specialty retailer’s stock valued at $10,238,000 after purchasing an additional 128,719 shares in the last quarter. AQR Capital Management LLC lifted its stake in Medifast by 117.5% during the 2nd quarter. AQR Capital Management LLC now owns 389,951 shares of the specialty retailer’s stock valued at $8,509,000 after acquiring an additional 210,669 shares during the period. American Century Companies Inc. boosted its holdings in shares of Medifast by 17.4% during the 2nd quarter. American Century Companies Inc. now owns 198,738 shares of the specialty retailer’s stock valued at $4,336,000 after acquiring an additional 29,476 shares during the last quarter. Jacobs Levy Equity Management Inc. grew its stake in shares of Medifast by 14.0% in the third quarter. Jacobs Levy Equity Management Inc. now owns 169,409 shares of the specialty retailer’s stock worth $3,242,000 after acquiring an additional 20,832 shares during the period. Finally, JPMorgan Chase & Co. raised its holdings in shares of Medifast by 156.1% during the third quarter. JPMorgan Chase & Co. now owns 57,455 shares of the specialty retailer’s stock valued at $1,100,000 after purchasing an additional 35,017 shares during the last quarter. 95.51% of the stock is currently owned by hedge funds and other institutional investors.

Medifast Stock Up 1.5 %

MED stock opened at $15.75 on Wednesday. The company has a market cap of $172.28 million, a price-to-earnings ratio of 23.86 and a beta of 1.15. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.55 and a current ratio of 3.11. The business’s 50-day moving average is $17.97 and its two-hundred day moving average is $18.59. Medifast, Inc. has a fifty-two week low of $14.94 and a fifty-two week high of $57.41.

Medifast (NYSE:MED) last issued its quarterly earnings data on Monday, November 4th. The specialty retailer reported $0.35 earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.50. The firm had revenue of $140.16 million for the quarter, compared to analysts’ expectations of $135.45 million. Medifast had a net margin of 1.09% and a return on equity of 15.98%. During the same quarter in the prior year, the business earned $2.12 EPS. As a group, analysts forecast that Medifast, Inc. will post 1.68 earnings per share for the current year.

Analysts Set New Price Targets

Separately, DA Davidson raised shares of Medifast from an “underperform” rating to a “neutral” rating and lifted their target price for the stock from $16.50 to $17.00 in a research report on Tuesday, November 5th.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.